When Hepatitis B Virus Meets Interferons

Chronic hepatitis B virus (HBV) infection imposes a severe burden on global public health. Currently, there are no curative therapies for millions of chronic HBV-infected patients (Lok et al., 2017). Interferon (IFN; including pegylated IFN) is an approved anti-HBV drug that not only exerts direct a...

Full description

Bibliographic Details
Published in:Frontiers in Microbiology
Main Authors: Guangyun Tan, Hongxiao Song, Fengchao Xu, Genhong Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-07-01
Subjects:
interferon
HBV
ISGs
HBV drug
cccDNA
TRIMs
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2018.01611/full

Internet

https://www.frontiersin.org/article/10.3389/fmicb.2018.01611/full

Similar Items